Anxiety — Patent Landscape
3
Approved drugs
31
Active US patents
64/100
Avg vulnerability
—
Annual revenue covered
Originators in Anxiety
Cliff calendar — next 15 years
4
28
15
29
6
32
4
34
2
38
Approved drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Valium
diazepam
|
Generic (originally Roche) | 21 | 67 | — | 2029-03-27 |
|
Versed
midazolam
|
Generic (originally Roche) | 6 | 61 | — | 2028-01-18 |
|
Ativan
lorazepam
|
Generic (originally Wyeth/Pfizer) | 4 | 64 | — | 2034-01-08 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 9289432 | Versed | method of use | 75 | 2028-01-18 |
| 9687495 | Versed | method of use | 75 | 2028-01-18 |
| 8217033 | Versed | method of use | 75 | 2028-01-18 |
| 12337061 | Valium | method of use | 75 | 2032-06-13 |
| 12337061 | Valium | method of use | 75 | 2032-06-13 |
| 12337061 | Valium | method of use | 75 | 2032-06-13 |
| 12324852 | Valium | method of use | 75 | 2032-10-16 |
| 12324852 | Valium | method of use | 75 | 2032-10-16 |
| 12324852 | Valium | method of use | 75 | 2032-10-16 |
| 8999393 | Ativan | method of use | 70 | 2034-01-08 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 10966990 | Versed | formulation | 42 | 2038-06-20 |
| 10966990 | Versed | formulation | 42 | 2038-06-20 |
| 8895546 | Valium | formulation | 55 | 2029-03-27 |
| 8895546 | Valium | formulation | 55 | 2029-03-27 |
| 8895546 | Valium | formulation | 55 | 2029-03-27 |
| 8809322 | Versed | formulation | 55 | 2028-01-18 |
| 8999393 | Ativan | method of use | 62 | 2034-01-08 |
| 8999393 | Ativan | method of use | 62 | 2034-01-08 |
| 8999393 | Ativan | method of use | 62 | 2034-01-08 |
| 11793786 | Valium | formulation | 63 | 2029-03-27 |
Related
- Anxiety — full disease profile
- AI Patent Landscape Report — type "anxiety" for an AI exec memo
- Company Patent Rankings
- Biosimilar Opportunity Scanner